MedPath

Examining the Feasibility of an Internet-Delivered Cognitive Behaviour Therapy program for emotional wellbeing among people with epilepsy.

Not Applicable
Completed
Conditions
Epilepsy
Anxiety
Depression
Mental Health - Depression
Mental Health - Anxiety
Neurological - Epilepsy
Registration Number
ACTRN12614001300662
Lead Sponsor
Dr Milena Gandy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria

18+ years of age.
- Confirmed diagnosis of epilepsy; which is being managed by a GP or specialist.
- Living in Australia.
- Has had a recent consultation (i.e., in the last 6 months) with a GP or specialist.
- Provide informed consent to participate in the study.

Exclusion Criteria

- Inability to use a computer.
- Severe depression (i.e., indicated by a score > 22 on the PHQ-9).
- Significant suicidal ideation (i.e., indicated by a score > 2 to Question 9 of the PHQ-9).
- Acutely suicidal or recent history of attempted suicide or self-harm (i.e., last 12 months).
- Serious cognitive impairment or dementia (<21 on the Telephone Interview of Cognitive Status; TICS).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient Health Questionnaire 9-Item (PHQ9) and Neurological Depressive Disorders Inventory for Epilepsy (NDDI-E), which are two measures of depression.[Application, pre-treatment, weekly during treatment (PHQ-9), post-treatment and 3 month follow-up.<br>];Generalized Anxiety Disorder 7-Item (GAD7), which is a measure of anxiety.<br>[Application, pre-treatment, weekly during treatment, post-treatment and 3 month follow-up.<br>];World Health Organisation Disability Assessment Schedule 2.0 (WHODAS-2), which is a measure of disability associated with living with a chronic health condition. [Pre-treatment, post-treatment and 3 month follow-up.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath